AGIF, Adipogenesis inhibitory factor, IL-11.
AGIF, Adipogenesis inhibitory factor, IL-11.
IL-11 has multiple effects on both hematopoietic and non-hematopoietic cells. Many of the biological effects described for IL-11 overlap with those for IL-6. In vitro, IL-11 can synergize with IL-3, IL-4, and stem cell factor (SCF) to shorten the G0 period of early hematopoietic progenitors . It also enhances IL-3-dependent megakaryocyte colony formation and stimulates the T cell-dependent development of specific immunoglobulin-secreting B cells .
The human IL-11 gene, consisting of 5 exons and 4 introns, is located on chromosome 19 and encodes a 23 kDa protein . IL-11 is a member of the IL-6-type cytokine family, distinguished based on their use of the common co-receptor gp130. Signal specificity is provided by the IL-11Rα subunit, which is expressed at high levels in fibroblasts and other stromal cells but not immune cells .
Recombinant human IL-11 (rhIL-11) was developed as the drug substance oprelvekin. It has been shown to have potent thrombopoietic activity in vivo and has been used therapeutically to ameliorate chemotherapy-induced thrombocytopenia . Recombinant human IL-11 is typically expressed in Chinese Hamster Ovary (CHO) cells or Escherichia coli and is supplied in a lyophilized form .
IL-11 has been found to stimulate cell proliferation of T11 cells and has been used in various research applications to study its effects on hematopoietic progenitors, megakaryocyte colony formation, and immunoglobulin-secreting B cells . It is also being explored for its potential therapeutic applications in treating various conditions related to the hematopoietic and immune systems .